| 4NCR: reference: Towards a new combination therapy for tuberculosis with next generation benzothiazinones., Makarov V, Lechartier B, Zhang M, Neres J, van der Sar AM, Raadsen SA, Hartkoorn RC, Ryabova OB, Vocat A, Decosterd LA, Widmer N, Buclin T, Bitter W, Andries K, Pojer F, Dyson PJ, Cole ST, EMBO Mol Med. 2014 Feb 5. PMID: 24500695 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).